Add like
Add dislike
Add to saved papers

Radiologists' preferences regarding content of prostate MRI reports: a survey of the Society of Abdominal Radiology.

PURPOSE: To evaluate radiologist preferences regarding specific content that warrants inclusion in prostate MRI reports.

METHODS: Sixty-one members of the Society of Abdominal Radiology responded to a 74-item survey regarding specific content warranted in prostate MRI reports, conducted in August 2016.

RESULTS: General items deemed essential report content by ≥ 50% of respondents were prostate volume (80%), extent of prostate hemorrhage (74%), TURP defects (69%), coil type (64%), BPH (61%), contrast dose (61%), contrast agent (59%), medications administered (59%), and magnet strength (54%). Details regarding lesion description deemed essential by ≥ 50% were overall PI-RADS category (88%), DCE (±) (82%), subjective degree of diffusion restriction (72%), T2WI intensity (72%), T2WI margins (65%), T2WI shape (52%), DWI 1-5 score (50%), and T2WI 1-5 score (50%). Details deemed essential to include in the report Impression by ≥ 50% of respondents were lymphadenopathy and metastases (100%), EPE (98%), SVI (98%), neurovascular bundle involvement (93%), index lesion location (93%), PI-RADS category of index lesion (82%), number of suspicious lesions (78%), significance of index lesion PI-RADS category (53%), and PI-RADS category of non-index lesions (52%). Preferred methods for lesion localization were slice/image number (68%), 3-part craniocaudal level (68%), zonal location (65%), anterior vs. posterior location (57%), and medial vs. lateral position (56%). Least preferred methods for localization were numeric sector from the PI-RADS sector map (8%), annotated screen capture (10%), and graphical schematic of PI-RADS sector map (11%).

CONCLUSION: Radiologists generally deemed a high level of detail warranted in prostate MRI reports. The PI-RADS v2 sector map was disliked for lesion localization.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app